Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 2, 2021
Clear
SKU: GMS-1252 Category:

OVERVIEW

The global market for biomarker technologies is projected to rise at a CAGR of 10.2 percent over the forecast period, owing to the COVID-19 pandemic. Growing healthcare spending, increased funding for R&D, and Biomarkers’ increasing utility for diagnostic purposes, as well as increased work on biomarkers, which lead to the market’s growth. The study forecasts short- and long-term developments that will affect the Biomarker Technologies market’s future, including the effect of the COVID-19 pandemic on the Biomarker Technologies industry.

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 1

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 2

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 3

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 4

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 5

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 6

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 7

Biomarker Technologies Market by Application (Biomarker Discovery), Profiling Technology (NGS, Immunoassay, PCR, Chromatography, Mass Spectrometry, Liquid Biopsy), Research Area (Proteomics, Lipidomics) – 2021 to 2026 8

TABLE OF CONTENT

1 Global Biomarker Technologies Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Biomarker Technologies Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Biomarker Technologies Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Biomarker Technologies Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Biomarker Technologies Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Biomarker Technologies Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Biomarker Technologies Market – By Test Type (Market Size – & million/billion)
8.1 Solid Biopsy
8.2 Liquid Biopsy

9 Global Biomarker Technologies Market – By Application
9.1 Clinical Diagnostics
9.2 Research
9.3 Drug Discovery & Development

10 Global Biomarker Technologies Market – By Application
10.1 Consumables
10.2 Instruments
10.3 Services
10.4 Software/Informatics

11 Global Biomarker Technologies Market – By Profiling Technology
11.1 Immunoassay
11.2 PCR
11.3 Imaging Technologies
11.4 Mass Spectrometry
11.5 NGS
11.6 Chromatography
11.7 Other

12 Global Biomarker Technologies Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Biomarker Technologies Market – Entropy
13.1 New product launches
13.2 M&A's, collaborations, JVs and partnerships

14 Global Biomarker Technologies Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Agilent Technologies
14.3 Thermo Fisher Scientific
14.4 Roche
14.5 Waters Corporation
14.6 Danaher Corporation
14.7 Shimadzu Corporation
14.8 Bio-Rad Laboratories
14.9 Company 8
14.10 Company 9
14.11 Company 10
14.12 Company 11 & more

15 Global Biomarker Technologies Market – Appendix
15.1 Sources
15.2 Abbreviations